Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Barnes & Noble fends off dissident shareholder

By Aaron Smith, staff writer


NEW YORK (CNNMoney.com) -- The bookseller Barnes & Noble said on Tuesday that shareholders rejected a bid by dissident investor Ronald Burkle to expand his ownership of the bookseller.

Barnes & Noble (BKS, Fortune 500) said the preliminary results showed that shareholders voted down an attempt by Burkle's investment firm, The Yucaipa Companies, to overturn a so-called poison pill, which caps Yucaipa's ability to own more stock in the company.

"We are pleased by the shareholder support we received," said Leonard Riggio, who was re-elected as board chairman and who owns more than one-third of the company's stock.

Yucaipa spokesman Frank Quintero said that its 19% share of Barnes & Noble stock makes it difficult to take on Riggio, who owns a 36% share. But he said that the majority of outstanding stockholders voted in favor of Yucaipa.

Yucaipa founder and chairman Burkle said, in a press release, that he wanted "to thank the independent stockholders who supported us by more than a wide margin."

He also said "it is nearly impossible to do something Leonard Riggio doesn't want to do because of his built-in voting advantage."  To top of page

Index Last Change % Change
Dow 21,750.73 -274.14 -1.24%
Nasdaq 6,221.91 -123.20 -1.94%
S&P 500 2,430.01 -38.10 -1.54%
Treasuries 2.20 -0.03 -1.21%
Data as of 9:29pm ET
Company Price Change % Change
Bank of America Corp... 23.64 -0.55 -2.27%
Cisco Systems Inc 31.04 -1.30 -4.02%
Advanced Micro Devic... 12.34 -0.29 -2.30%
KeyCorp 17.79 -0.19 -1.06%
Chesapeake Energy Co... 3.88 -0.12 -3.00%
Data as of 4:15pm ET
Sponsors

Sections

The Congressional Budget Office narrows its projection for when Treasury will run short on money if Congress doesn't raise or suspend the country's debt ceiling. More

It's tempting to take a chunk of cash just sitting there and put it to work in the market. But it's risky. There are better ways to get some return on your money. More

approved.blancoo
asmith.oblanco